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Abstract
Background: Real-time PCR methods are increasingly used 
in routine patient care settings not only to determine the 
presence or absence of pathogens in patient materials, but 
also to obtain semiquantitative results to estimate the path-
ogen load. However, it is so far unknown how well these 
methods are harmonized among different laboratories.
Methods: Sets of stool samples were distributed three to 
four times per year to ca. 25–40 participating laboratories 
within the European Union as part of an external quality 
assessment scheme (EQAS) for the detection of gastroin-
testinal protozoa. This paper presents the results obtained 
over a 3-year period for Entamoeba histolytica, Entamoeba 
dispar, Giardia lamblia, Cryptosporidium species and 
Dientamoeba fragilis.
Results: Although both false-positive and false-negative 
results were reported, the overall sensitivity and specificity 
were high. The substantial differences in the quantitative 
output of the real-time PCR assays could be traced back to 
differences in DNA isolation procedures between different 
laboratories.
Conclusions: Participation in an EQAS proved to be impor-
tant as it provides information on how the real-time PCR 
methods used by the participant compares to the gener-
ally reported results and indicates how procedures could 
be improved. Semiquantitative results of real-time PCR 
methods are not exchangeable between laboratories as 
long as the diagnostic procedures are not harmonized. 
Intralaboratory comparison of semiquantitative real-time 
PCR results seems only possible by the use of calibration 
curves derived from well-validated standards in clinical 
material and not by spiking solutions with purified DNA.
Keywords: Cryptosporidium; Dientamoeba fragilis; Enta-
moeba histolytica; external quality assessment scheme; 
Giardia lamblia; intestinal protozoa; real-time PCR.
Introduction
Classical methods used for detection of pathogens in 
clinical microbiology are mainly based on culture (viruses 
and bacteria) and microscopy (parasites). However, these 
time-consuming and labor-intensive methods are more 
and more replaced by molecular methods, of which many 
are based on RNA or DNA amplification. Because real-time 
PCR methods show high sensitivity and specificity and 
generate results fast, they are abundantly used for detec-
tion of pathogens in patient materials, such as blood, 
spinal fluid, urine and stool [1]. For some infectious dis-
eases, it is sufficient that the method provides a reliable 
qualitative answer; i.e. is the pathogenic microbe present 
or absent, as treatment strategy is not influenced by the 
detected concentration of microbes. However, quantifi-
cation might be relevant in specific cases. For example, 
the intensity of infection might reflect the severity of the 
infection (e.g. Plasmodium falciparum). Microbes can 
also be present in low quantities in immune-competent 
patients not causing any symptoms, while causing severe 
symptoms or even fatal disease in immune-compromised 
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patient (e.g. Pneumocystis jiroveci). Therefore, real-time 
PCR assays are currently used in routine patient care set-
tings also to semiquantitatively estimate the pathogen 
load as an indicator for disease severity [2–5]. In addi-
tion, semiquantitative PCR assays are also used for epi-
demiological studies in which the detected pathogen load 
is used to estimate the infection intensities, for instance, 
during eradication programs for helminth infections [6, 7]. 
Although real-time PCR methods beyond any doubt 
provide semiquantitative results, it is so far unknown how 
well these methods are harmonized among distinct labo-
ratories, in particular when dealing with the detection of 
parasitic infections.
In 2013, the Dutch Foundation for Quality Assess-
ment in Medical Laboratories (SKML) launched an exter-
nal quality assessment scheme (EQAS) for detection of 
gastrointestinal parasitic protozoa in stool by molecular 
methods based on DNA amplification, in order to gain 
insight into the qualitative as well as quantitative perfor-
mance of this assay in routine patient care. In contrast to 
other EQAS organizations, which distribute purified DNA 
in an artificial matrix, the SKML-EQAS exclusively uses 
unpreserved clinical stool specimens in their distribution 
rounds. Hence, by using this commutable stool material, 
the entire laboratory procedure used for clinical specimens 
can be evaluated, thereby providing a reliable indication 
of the qualitative performance of methods used as well as 
the quantitative variation between different laboratories. 
Here we report the results over a 3-year period from the 
SKML-EQAS for the detection of the gastrointestinal para-
sitic protozoa Entamoeba histolytica,  Entamoeba dispar, 
Giardia lamblia, Cryptosporidium species and Dienta-
moeba fragilis in stool and provide recommendations on 
how to improve molecular detection of these protozoa.
Materials and methods
Distribution of stool samples in a quality control scheme
Sets of three to four  stool samples have been distributed three to 
four times per year by regular mail to ca. 25–40 participating labo-
ratories within the European Union. This EQAS has been part of a 
broad EQAS panel provided by the SKML. Hence, the distribution ful-
fills all regulations applying to a proper EQAS, such as anonymiza-
tion, ethical approval and standardization (see www.skml.nl/en for 
details). To obtain a performance score, participants had to report 
their results, i.e. the protozoa species detected with the correspond-
ing quantification cycle (Cq)-value (Cq; the PCR-cycle at which the 
fluorescence from PCR amplification exceeds the background fluo-
rescence), within 2 weeks after receiving the samples via an Internet-
based entry point. Here we report the participants findings of the 
period 2013–2015.
Materials
Four weeks prior to each scheduled distribution round, seven 
Dutch expert-laboratories for parasitology, all members of the par-
asitology section of the SKML-EQAS foundation, were requested to 
select stool samples containing one or more of the following pro-
tozoa in sufficiently high concentrations; E. histolytica, E. dispar, 
G. lamblia, Cryptosporidium species or D. fragilis. These selected 
stool samples were all derived from a routine diagnostic laboratory 
setting. They were send to the SKML-EQAS coordinating Depart-
ment of Medical Microbiology and Infectious Diseases, Erasmus 
University Medical Centre, Rotterdam, the Netherlands, for further 
processing in order to prepare a stable and homogeneous stool sus-
pension. From there, samples were further distributed in 0.5-mL 
aliquots.
Validation of materials
Inter- and intralaboratory variation was evaluated for each selected 
stool suspension by sending one aliquot to each of the seven expert-
laboratories, as well as five aliquots to a single laboratory. All testing 
was done blinded, and the results were reported to the coordinating 
laboratory without knowing the outcome of the other expert-labo-
ratories. To label a sample as being positive for a specific target, all 
expert reference laboratories had to be unanimous in their qualita-
tive result. A suspension was considered to be homogeneous when 
the test results of the five aliquots showed an acceptable intralabora-
tory variation, which was defined as follows: all Cq-values should fall 
within the range of the average Cq ± 2 times the standard deviation, 
or otherwise the difference between the lowest and the highest test 
result of all five measurements should not be more than 2 Cq. In some 
of the suspensions, one or more protozoa species were present in 
such a low concentration that detection by all participating laborato-
ries could not be guaranteed. In such a case, the suspension was still 
distributed, but examination of that particular target was considered 
‘educational’, which means that no performance score was awarded 
to the participants for that particular target.
The stability of the protozoa in the unpreserved stool sam-
ples was thoroughly investigated before the EQAS was launched. 
Analysis of stool, which had been stored at room temperature for 
2 weeks before distribution to the expert-laboratories, demonstrated 
a decrease of <2 Cq-values for all examined protozoa, including 
D.  fragilis, over that period. Subsequently, the stability of targets in 
the stool samples was monitored by the expert-laboratories by exam-
ining these samples not only prior to distribution to the participants 
but also as actual participants in the EQAS. Substantial differences in 
reported Cq-values between these two examination time points were 
never observed.
On one occasion participants received a purified DNA sample of 
a stool that contained G. lamblia in addition to a sample of the origi-
nal stool suspension. This was to explore possible causes of reported 
differences in Cq-values, in particular to discriminate within the 
entire diagnostic procedure the outcome of DNA isolation from DNA 
amplification.
Finally, a questionnaire was send out asking for details on the 
used analytical procedures, including applied dilution factors, the 
volume of diluted stool from which DNA was isolated, the volume of 
purified DNA eluted and the volume of eluted DNA used in the PCR. 
Brought to you by | Universiteit Leiden / LUMC
Authenticated
Download Date | 8/21/19 1:36 PM
1724      Schuurs et al.: Harmonization of PCR-based detection methods for intestinal protozoa
This information was used to calculate per participant, the amount 
of stool from which the input DNA for the PCR was derived.
Results
Between 2013 and 2015, the number of participants in the 
SKML-EQAS for molecular detection of gastrointestinal 
protozoa laboratories increased from approximately 25 to 
40 laboratories. Over these 3 years, participants received 
27  stool samples divided over 11 distributions. The pro-
vided stool samples contained a variable composition 
of protozoa: zero to maximally three species. In total, 
the distributed samples comprised 10× G. lamblia, 4× 
E.   histolytica, 6× Cryptosporidium species, 11× D.   fragilis 
and 3× E. dispar. Some participants reported results for 
only a subset of these five targets, and therefore, the 
number of reported results varied from target to target 
(Table 1).
All gastrointestinal protozoa were detected with a 
high sensitivity (>96%), except for E. histolytica, which 
was detected with an overall sensitivity of 85% (Table 1). 
The frequency of false-negative results was correlated to 
lower pathogen loads (Figure 1). In addition, out of the 631 
reported results, eight were false positive; G. lamblia (4 ×, 
1.6%), E. histolytica (1 ×, 0.9%) and D. fragilis (3 ×, 2.5%). 
Two of these false-positive results were probably caused 
by an administrative error, as the intended results for 
sample 1 were reported for material 2 and vice versa.
The false-negative results suggest that the distinct 
methods used by the participants vary in sensitivity. 
Therefore, the semiquantitative results were analyzed by 
comparison of the reported Cq-values, which represents 
the number of DNA amplification cycles that are needed 
to produce a fluorescent signal that exceeds the threshold 
value of the real-time PCR. Because the amount of target 
DNA is amplified exponentially during the PCR, a differ-
ence of N cycles in Cq-value corresponds theoretically to a 
difference of 2N in sensitivity to detect target DNA present 
in the examined stool specimen.
Despite the homogeneous load of protozoa in each 
distributed stool sample, as reflected by the small varia-
tions (<2 cycles) when examined in fivefold by one of the 
expert-laboratories, a difference was observed between 
participants of at least 10 amplification cycles in reported 
Cq-values (Figure 2). Variance in reported Cq-values (Cq) 
may, in part, be explained by the different ways of meas-
uring these values (cycle threshold [Ct] versus crossing 
point [Cp] cycle is a different way to determine the cycle 
at which fluorescence from PCR amplification exceeds 
the background fluorescence) and/or laboratory (and 
apparatus)-specific settings and can also be indicative 
for sensitivity differences. Indeed, laboratories present-
ing relatively low Cq-values never reported false-negative 
results for that particular pathogen, as indicated by the 
green box in Figure 2A. Altogether, these findings suggest 
that some participants use a more sensitive method to 
detect the target DNA compared to other participants.
If the same analysis was performed for other targets, a 
similar pattern was observed (compare Figure 2A and B). 
On the other hand, participants that report relatively 
Table 1: Sensitivity (%) of detection of gastrointestinal protozoa in distributed stool samples.
  Giardia lamblia   n   Cryptosporidium spp.   n   Entamoeba histolytica   n   Dientamoeba fragilis   n
2013  98.8   85   92.0   38   77.0   26   n.d.   –
2014  96.4   84   100.0   54   83.0   52   98.0   48
2015  98.8   85   96.0   57   97.0   29   100.0   73
Total   98.0   254   96.6   149   85.0   107   99.2   121
Data for E. dispar are not shown, as only five to seven participants reported results for this protozoa. n, number of reported results (number 
of  participants × number of distributed samples validated positive of that particular protozoa); n.d., not distributed.
Figure 1: Correlation between the number of reported false-nega-
tive results and the parasite load.
Each dot represents a specimen for which the number of reported 
false-negative results is plotted on the y-axis and the parasite load 
on the x-axis (expressed as the median of reported Cq-values). 
Results are shown for Giardia lamblia (black dots), Cryptosporidium 
species (blue triangles), Entamoeba histolytica (purple squares) and 
Dientamoeba fragilis (green diamonds). Stool samples for which no 
false-negative results were reported are not included in the graph.
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low Cq-values for one PCR target did not necessarily also 
reported low Cq-values for another target, as for instance 
the participant shown far right on the x-axis in Figure 2B 
reported relatively high Cq-values for G. lamblia but low 
Cq-values for Cryptosporidium spp. (Figure 2C). These 
findings suggest that the differences in reported Cq-values 
are caused by not only differences in efficiency of DNA 
extraction from stool but also differences in DNA ampli-
fication efficiency.
Figure 3 compares the outcome in reported Cq- values 
of the purified DNA sample of a stool that contained 
G.  lamblia, to the original stool suspension. Similar to 
Figure  1, a range of more than 13 cycles was seen in the 
reported Cq-value for the analyzed stool sample. Likewise, 
a large difference (>12 cycles) was reported in the Cq-values 
for the purified DNA sample, illustrating a substantial dif-
ference in efficiency of the PCR methods used to amplify 
G.  lamblia DNA. Participants that reported relatively low 
 Cq-values for stool samples (Figure 3, green box), a result 
mirroring the entire diagnostic procedure of DNA isolation 
and amplification, also reported a relatively low Cq-value 
for the purified DNA sample. Participants that reported 
relatively high Cq-values for stool samples (Figure 3, red 
box) could be divided into two groups; some reported a rel-
atively high Cq-value for the purified DNA sample (Figure 3, 
purple oval) but most reported a relative low Cq-value. In 
cases where the participant reported a high Cq-value for 
stool and low Cq-value for DNA, it seems that DNA is ampli-
fied efficiently and that the DNA isolation method could 
be improved. In cases where high Cq-values were reported 
for both the stool and the DNA sample, it seems that the 
DNA amplification method could be improved. It can be 
Figure 2: Reported Cq-values for stool samples positive of   Entamoeba 
histolytica (A), Giardia lamblia (B) and Cryptosporidium spp. (C).
Each dot represents a reported Cq-value by a single participant for a 
single stool sample. The reported Cq-values are plotted on the y-axis 
expressed as the reported Cq-value of the individual participant 
subtracted by the median of reported Cq-value of all participants. A 
dot with a negative y-axis value thus represents a reported Cq-value 
lower than the median of all participants and vice versa. Each lane 
on the x-axis represents an individual participant. Please note 
that the order in which the participants are plotted on the x-axis is 
identical in panels B and C but differs from that in panel A. Orange, 
red and yellow markers plotted on the x-axis indicate a reported 
false-negative result for a sample with a high parasite load (median 
of reported Cq-value <35; red marker), a low parasite load (median 
of reported Cq-value >35; orange) and errors presumably caused by 
sample exchange, respectively. The small horizontal lines indicate 
the average difference in reported Cq-value by the participant com-
pared to the median reported Cq-value of all participants.
Figure 3: Reported Cq-values for Giardia lamblia in stool (black 
dots) and purified DNA (blue dots) specimens.
The reported Cq-values are plotted on the y-axis expressed as the 
reported Cq-value of the individual participant subtracted by the 
median of reported Cq-value of all participants. Each lane repre-
sents a single participant and the order in which the participants 
are plotted on the x-axis differs from that in Figures 1 and 2.
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concluded that that differences in sensitivity among par-
ticipants are probably caused by differences in efficiency of 
both DNA extraction as well as DNA amplification methods.
Around 75% (23/32) of the participants responded 
to the questionnaire asking for details on the used ana-
lytical procedures. No correlation was seen between the 
reported Cq-values and the methods and machinery used 
for DNA isolation, the amplification procedure or any pre-
treatment protocol (e.g. bead beating, freeze-thawing). By 
contrast, an association was noticed between the reported 
Cq-values and the amount of stool from which the input 
DNA for the PCR was derived, which differed over 80-fold 
(corresponding to >26) among participants. The observed 
pattern in the relation between the amount of input DNA 
[defined as the amount of stool (in μL) from which the 
input DNA was derived] and the reported Cq-values sug-
gests an optimal amount of used stool specimen, which 
was in this case circa 5 μL (Figure 4). The use of a smaller 
amount of stool, i.e. >4 μL of this specimen, or a larger 
amount of stool, i.e. more than 5 μL of this specimen, 
resulted in an increase of the reported Cq-value.
Discussion
To the best of our knowledge, this is the first study report-
ing the outcome of an EQAS for molecular detection of 
protozoa in unpreserved stool specimens. Analysis of the 
results of ca. 25–40 participating European laboratories 
over a 3-year period demonstrates high sensitivity of real-
time PCR methods in routine diagnostic settings, confirms 
what has been shown before in numerous studies by com-
paring real-time PCR performance with more traditional 
microscopy-based methods [8–11]. Still, the occurrence of 
a few false-negative and false-positive results clearly dem-
onstrated that participation within an EQAS is essential 
for proper quality control of each individual diagnostic 
laboratory, as suggested earlier [12].
Analysis of the reported semiquantitative results (Cq-
values) demonstrated that the efficiency of the methods 
used for DNA isolation as well as target-DNA amplifica-
tion varies substantially among distinct laboratories, as 
the interlaboratory variation was >10 Cq-values, whereas 
the intralaboratory variation was always small (<2 Cq-val-
ues). Variations in the amount of input DNA for the PCR, 
defined as the amount of stool used for DNA extraction, 
appeared to be a very important factor determining the 
interlaboratory variation. When the volume is too small, 
the amount of protozoa present might be limiting; when 
the volume is too large, DNA amplification inhibiting 
factors might interfere with the amplification process.
Besides the amount of stool used for DNA isolation, 
there are likely to be other causes of variation between 
participants such as the selected DNA target, the designed 
primers, the quality of the DNA polymerase, the actual 
PCR settings and the mathematical method used to deter-
mine the point at which the fluorescent signal exceeds 
the threshold. However, the number of participating 
laboratories was too low and the range of used molecular 
procedures was too high to pinpoint any additional key 
factors.
Our findings clearly illustrate that semiquantitative 
results of real-time PCR methods are not exchangeable 
between laboratories as long as diagnostic procedures 
are not harmonized. Most laboratories aim to standardize 
their overall molecular methods in order to combine the 
detection of a whole range of microorganisms. Such an 
intralaboratory standardization will lead to efficient use 
of materials, equipment and time and thus to a reduction 
in costs. On the other hand, interlaboratory standardiza-
tion is less common. Laboratories are keen to continue 
using their own local settings for DNA isolation and per-
formance of real-time PCR and are not easily persuaded 
to adapt procedures in full detail in order to harmonize 
protocols between laboratories. A possible way forward 
to achieve more comparable qualitative results between 
different laboratories could be the introduction of a cali-
bration curve derived from well-validated standards. 
Based on our findings, it is recommended to prepare such 
validated standards by the use of actual clinical material 
Figure 4: Correlation between the reported Cq-value and the 
amount of input DNA for the real-time PCR.
The reported Cq-values are plotted on the y-axis expressed as the 
reported Cq-value of the individual participant subtracted by the 
median of reported Cq-value of all participants. The amount of input 
DNA for the DNA is defined as amount of stool (in μL) from which the 
input DNA was derived. The red dot represents a reported false-
negative result from a participant that used input DNA derived from 
0.9 μL of stool.
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(stool, urine, serum, etc.) and not by spiking solutions 
with purified DNA.
In conclusion, by evaluating the EQAS data, we have 
shown that substantial differences in the quantitative 
output of real-time PCR for the detection of intestinal pro-
tozoa could be traced back to differences in DNA isolation 
procedures between distinct laboratories, and we con-
firmed the importance of participating in an EQAS when 
performing real-time PCR in a clinical routine laboratory 
setting.
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